Original Research
Accepted on 19 Jul 2024
Neurological manifestations of immune origin after COVID19 vaccination: Retrospective case study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1376474
Type at least 3 characters
2,146 articles
Articles
Original Research
Published on 19 Jul 2024
Melatonin modulates TLR4/MyD88/NF-ÎşB signaling pathway to ameliorate cognitive impairment in sleep-deprived rats
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1430599
- 126 views
Original Research
Accepted on 18 Jul 2024
Effect of Dexmedetomidine on ncRNA and mRNA Profiles of Cerebral Ischemia-Reperfusion Injury in Transient Middle Cerebral Artery Occlusion Rats Model
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1437445
Case Report
Published on 18 Jul 2024
Case report: Dezocine’s rapid and sustained antidepressant effects
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411119
- 124 views
Original Research
Published on 18 Jul 2024
Phosphodiesterase 7 inhibitor reduces stress-induced behavioral and cytoarchitectural changes in C57BL/6J mice by activating the BDNF/TrkB pathway
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411652
- 150 views
Original Research
Published on 17 Jul 2024
Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1439115
- 216 views
Systematic Review
Published on 17 Jul 2024
Locomotion changes in methamphetamine and amphetamine withdrawal: a systematic review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1428492
- 158 views
Review
Published on 16 Jul 2024
The multifaceted effects of fluoxetine treatment on cognitive functions
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1412420
- 237 views
Original Research
Accepted on 15 Jul 2024
Melatonin Improves Cognitive Dysfunction and Decreases Gliosis in the Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1447757
- 107 views
Editorial
Accepted on 15 Jul 2024
Recent Advancements in Intratympanic Drug Delivery Systems: How and Why
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1464254
Original Research
Accepted on 15 Jul 2024
CM082 Suppresses Hypoxia-Induced Retinal Neovascularization in Larval Zebrafish
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1336249
Editorial
Published on 15 Jul 2024
Editorial: Targeting mitochondrial dysfunction for the diagnosis and treatment of Alzheimer’s and cognitive-related diseases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1455646
- 222 views
Original Research
Accepted on 12 Jul 2024
Real-World Study of Adverse Events Associated with Gepant Use in Migraine Treatment Based on the VigiAccess and U.S. Food and Drug Administration's Adverse Event Reporting System Databases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1431562
Original Research
Accepted on 12 Jul 2024
Effect of lateral septum vasopressin administration on reward system neurochemistry and amphetamine-induced addictive-like behaviors in female rats
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411927
Original Research
Published on 12 Jul 2024
Neuroprotective effects of total phenolics from Hemerocallis citrina Baroni leaves through the PI3K/AKT pathway
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1370619
- 300 views
Original Research
Accepted on 11 Jul 2024
Efficacy and Safety of Levetiracetam for Migraine Prophylaxis in Children: A Systematic Review and Meta-Analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1407897